Rare diseases
Investigational molecules
Locations
Back to Austria55 clinical trials in Feldkirch, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effects of Carboplatin and Cisplatin in Patients with Early-Stage, Intermediate-Risk Cervical Cancer
AustriaPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
AustriaA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
AustriaStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
AustriaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
AustriaStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
AustriaStudy on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis
AustriaStudy on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels
AustriaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
AustriaStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
AustriaStudy of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer
AustriaStudy Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments
AustriaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on multiple myeloma, breast cancer, and lung cancer treatments. Research includes evaluation of novel therapeutic combinations and targeted therapies for various cancer types.
Several trials are investigating innovative approaches for both early-stage and metastatic diseases.
Clinical trials examining new treatments for stroke prevention and cardiac conditions. Research includes studies on novel anticoagulants and preventive therapies.
Focus on reducing major adverse cardiovascular events and improving patient outcomes.
Innovative research in chronic kidney disease, plaque psoriasis, and other specialized conditions. Studies evaluate both new treatments and improved therapeutic approaches.
Trials aim to advance treatment options and improve quality of life for patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
